DEKA ACE Pump System

FDA 510(k) K213536 · Deka Research and Development

Substantially Equivalent

510(k) numberK213536

Submission

Device name
DEKA ACE Pump System
Applicant
Deka Research and Development
Manchester, NH, US
Received
November 5, 2021
Decision date
July 25, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QFG – Alternate Controller Enabled Insulin Infusion Pump
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5730
Specialty
Clinical Chemistry

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to…

Other 510(k)s with product code QFG

510(k)DeviceApplicantDecision
K260001Mint ACE PumpQFG · Traditional Beta Bionics, Inc.09/11/2026SE
K261672twiist Automated Insulin Delivery (AID) SystemQFG · Special Deka Research and Development06/17/2026SE
K253976iLet ACE PumpQFG · Traditional Beta Bionics, Inc.04/30/2026SE
K253743MiniMed Flex pumpQFG · Traditional Medtronic Minimed, Inc.03/12/2026SE
K253470MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894)QFG · Traditional Medtronic Minimed, Inc.01/15/2026SE
K253074Tandem Mobi insulin pump with interoperable technologyQFG · Traditional Tandem Diabetes Care, Inc.11/06/2025SE
K252770iLet ACE PumpQFG · Special Beta Bionics, Inc.09/29/2025SE
K250792t:slim X2 insulin pump with interoperable technologyQFG · Traditional Tandem Diabetes Care, Inc.09/24/2025SE
K251032MiniMed 780G insulin pumpQFG · Traditional Medtronic Minimed, Inc.07/01/2025SE
K250930twiist systemQFG · Special Deka Research & Development Corp.04/02/2025SE

More from Deka Research & Development Corp.

510(k)DeviceDecision
K261672twiist Automated Insulin Delivery (AID) SystemQFG · Special 06/17/2026SE
K261530iiSure Infusion SetFPA · Special 06/03/2026SE
K243841Sparta Infusion Set for InsulinFPA · Traditional 08/01/2025SE
K241736Remunity 2.0 Pump for Remodulin (treprostinil) InjectionFRN · Traditional 01/16/2025SE
K242693DEKA Infusion System, DEKA Administration SetLDR · Special 10/07/2024SE
K240920HemoCare Bicarbonate Concentrate Set (BCS)KPO · Traditional 07/12/2024SE
K233557HemoCare Hemodialysis SystemKDI · Traditional 07/12/2024SE
K240256Remunity SystemQJY · Traditional 06/12/2024SE
K241178DEKA ACE Pump SystemQFG · Special 05/24/2024SE
K234055DEKA LoopQJI · Traditional 03/13/2024SE

Questions and answers

When was DEKA ACE Pump System cleared by the FDA?

DEKA ACE Pump System (K213536) received a 510(k) decision of Substantially Equivalent on July 25, 2023, 627 days after the submission was received.

What is the product code of K213536?

The FDA product code is QFG – Alternate Controller Enabled Insulin Infusion Pump, a Class II (moderate risk) device regulated under 21 CFR 880.5730.